Anti-aging Drugs Market By Drug Type (Senolytics, NAD+ Boosters, mTOR Inhibitors, Antioxidants, Hormonal Therapies, Stem Cell-based Drugs, Others), By Application (Skin Aging, Neurodegenerative Diseases, Cardiovascular Aging, Diabetes and Metabolic Disorders, Musculoskeletal Disorders, Others), By Route of Administration (Oral, Injectable, Topical, Others), By End-User (Hospitals, Clinics, Home Healthcare, Research Institutes, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Drug Type

• Senolytics
• NAD+ Boosters
• mTOR Inhibitors
• Antioxidants
• Hormonal Therapies
• Stem Cell-based Drugs
• Others

By Application

• Skin Aging
• Neurodegenerative Diseases
• Cardiovascular Aging
• Diabetes and Metabolic Disorders
• Musculoskeletal Disorders
• Others

By Route of Administration

• Oral
• Injectable
• Topical
• Others

By End-User

• Hospitals
• Clinics
• Home Healthcare
• Research Institutes
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Calico Life Sciences
• Unity Biotechnology
• Juvenescence Ltd.
• BioAge Labs
• Elysium Health
• Life Biosciences
• Rejuvenate Bio
• Insilico Medicine
• AgeX Therapeutics
• Samumed (now Biosplice Therapeutics)
• Longeveron Inc.
• Oisin Biotechnologies
• Gerostate Alpha
• Turn.Bio
• Genentech